Compared with once-daily comparators, once-weekly icodec was associated with similar safety and efficacy outcomes regardless of race, ethnicity, or age. The hypoglycemic profile and efficacy of ...

Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults receiving once-weekly semaglutide 1 mg had a ...